Cancer Nanotheranostics : Volume 2 / / edited by Muthupandian Saravanan, Hamed Barabadi

• Record Nr.: UNINA9910502646403321
• Autore: Saravanan Muthupandian
• Pubbl/distr/stampa: Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
• ISBN: 3-030-76263-7
• Edizione: [1st ed. 2021.]
• Descrizione fisica: 1 online resource (379 pages) : illustrations
• Collana: Nanotechnology in the Life Sciences, , 2523-8035
• Disciplina: 616.9940072
• Soggetti: Cancer; Nanomedicine; Nanobiotechnology; Cancer Nanotechnology; Cancer Biology; Càncer; Llibres electrònics
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Nota di bibliografia: Includes bibliographical references.
• Nota di contenuto: Preface -- Nanotheranostics -- Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics -- Nano-Oncology -- Cancer-Targeted Nanotheranostics -- Nanotheranostics -- Cancer Nano-Immunotherapy -- Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics -- Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy -- Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics -- Nanoerythrosome -- Role of Artificial Intelligence in Cancer Nanotheranostics -- Limitations of Current Cancer Nanotheranositcs -- Safety of nanobiomaterials for Cancer Nanotheranostics -- Index.
• Sommario/riassunto: Cancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows. In the first volume of Cancer Nanotheranostics, we discussed the role of different nanomaterials for cancer therapy including lipid-based ; nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies. This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research.